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Regression coefﬁcient estimates using 4.9% gain to 4.9% loss as reference group
Variable WOMAC Function WOMAC Pain
Weight Change
>10% reduction 4.07 (1.5, 6.7) 0.9 (0.1, 1.7)
5-9.9% reduction 0.1 (-1.9, 1.9) 0.3 (-0.9, 0.4)
5-9.9% gain 1.1 (-0.9, 3.1) 0.5 (-0.1, 1.2)
>10% gain -5.4 (-8.7, -2.0) -1.6 (-2.6, -0.5)
Base WOMAC 0.4 (0.3, 0.5) 0.5 (0.4, 0.6)
Sex -1.6 (-2.9, -0.4) -0.4 (-0.8, 0.1)
Comorbidity -1.3 (-1.9, -0.6) -0.3 (-0.6, -0.1)
Depression -2.0 (-3.7, -0.3) -1.0 (-1.5, -0.4)
Constant -4.2 (-6.7, -1.7) -1.7 (-2.6, -0.9)
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S179patients with symptomatic knee OA that weight changes of >10% have
potential to lead to appreciable changes in pain and function.353
IMPLANT SURVIVAL AFTER A TOTAL HIP OR KNEE REPLACEMENT IN
CATALONIA UP TO FIVE YEARS OF FOLLOW-UP: A POPULATION-
BASED REGISTER (RACAT)
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Purpose: The Catalan Arthroplasty Register (RACat for its acronym in
Catalan language) was set up by the Catalan Society of Orthopaedic
Surgery, the Catalan Health Service and the Catalan Agency for Health
Technology Assessment and Research to collect information and to
monitor the performance of all hip and knee replacement operations.
Competing risk with death can lead to inaccurate estimates of failure rates
if this is not taken into account in the analysis. This issue is particularly
important in elderly populations. We used the information collected in the
RACat to study the cumulative incidence of prosthesis failure accounting
for death as a competing risk. Secondly, we also investigated differences in
revision risk between the different types of prosthesis ﬁxation: cemented
vs hybrid vs uncemented.
Methods: The RACat uses 4 sources of information: information provided
ad-hoc by professionals from the hospital where surgery was carried out,
the Central Insurance Register (RCA), the ofﬁcial national hospital
discharge episodes database and companies that manufacture and
distribute prostheses. Prosthesis survival is the main outcome measure
used in the RACat and comprises the time elapsed between the date of
primary arthroplasty and the date when ﬁrst revision surgery (deﬁned as
any intervention involving the removal or replacement of any component
of the prosthesis) was carried out (if any). Date of death was provided by
the RCA register. Standard survival analysis based on Kaplan-Meier esti-
mation was performed and a competing risks ﬂexible parametric propor-
tional hazards model was applied to treat death as a competing event. Age
and gender-adjusted sub-hazard ratios for failure were calculated for each
prosthesis ﬁxation type using these same methods.
Results: The number of hip arthroplasties registered during the 2005-2010
period was 21,486, and corresponding revision arthroplasties accounted
for 11.4% (n¼2,658) of these. Overall total hip arthroplasty failures
cumulative incidence rate at one year of follow-up was 2.1%(95%CI 1.8%-
2.4%) rising to 3.1%(2.8%-3.5%) by year 3, and 3.9%(3.5%-4.5%) by year 5.
Non-signiﬁcantly lower rates were seen among cemented prostheses
when compared to uncemented and hybrid prostheses: age and gender-
adjusted SHR 1.09 [0.71 to 1.69]; p¼0.686 [see Figure 1a].
A total of 33,165 total knee arthroplasties were registered in RACat in the
same period, and revision arthroplasties accounted for 9.8% (n¼3,240) of
them. Overall knee revision cumulative incidence at one year after primarysurgery was 1.3%(1.2%-1.4%) rising to 3.8%(3.5%-4.0%) by year 3, and to
5.1%(4.6%-5.3%) by year 5. According to prosthesis ﬁxation type, lowest
rates were associated with hybrid prostheses when compared to unce-
mented and cemented: adjusted SHR 0.69 [0.56 to 0.85]; p<0.0001 [see
Figure 1b].
Conclusions:We provide for the ﬁrst time accurate estimates of prosthesis
survival in a southern European region, taking into account death as
a competing event. Future studies are needed in order to identify poten-
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Purpose:Womenwith OA suffer more pain and functional limitations than
men. However, they often have more severe radiographic OA, so that their
greater levels of pain and functional limitations may be due tomore severe
disease. The purpose of this study was to determine whether, at the same
level of radiographic knee OA grade, men and women signiﬁcantly differ in
severity of knee pain, functional limitations or disability.
Methods: Adults age 50-79 years with knee OA or known risk factors for
knee OA were enrolled. Weight-bearing, ﬁxed-ﬂexed posteroanterior and
lateral radiographs were graded using the Kellgren-Lawrence (KL) scale.
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instruments respectively. Severity of knee pain was assessed on a 0-100
numeric rating scale and subjects provided information on depressive
features (CES-D), educational level, race, co-morbid conditions (Charlson)
and use of pain medications. The presence of widespread pain was
determined. Subjects who reported a knee steroid injection in the past
year or were missing x-ray, knee pain, function or disability data were
excluded. Pain analyses were knee-based, stratiﬁed by KL grade and used
generalized estimating equations to control for covariance between knees.
Physical function and disability analyses were person-based and utilized
general linear models. For person-based analyses, subjects were grouped
by the combination of maximum KL grade and the contralateral knee KL
grade. Some groups were combined to increase the number of subjects per
level as follows: KL grade <2/<2, 2/<2, 2/2, 3/<2, 3/2, 3/3 and 4/0-4.
Analyses evaluated whether there were signiﬁcant sex differences in each
group of knees before and after adjustment for age, BMI, co-morbidity,
CES-D, clinic site, educational level, frequent use of pain medications, race,
and widespread pain.
Results: A total of 2731 subjects (5462 knees) were included in the anal-
yses. Men and women did not signiﬁcantly differ in age (62.08.3 vs.
62.37.9 years), BMI (30.45.1 vs. 30.66.3 kg/m2) or comorbid conditions
(p¼0.3734). More women than men had CES-D scores above a depression
screening cutoff (13.5% vs. 7.8%, p<0.0001), widespread pain (56.2% vs.
40.5%, p<0.0001) and bilateral knee OA (27.3% vs. 21.2%, p¼0.0003). A
greater percentage of men than women reported frequent salicylate
analgesic use (46.2% vs. 34.4%) while a greater percentage of women used
NSAIDs on a frequent basis (26.9% vs. 19.6%, all p<0.0001).
Women reported signiﬁcantly greater knee pain severity compared with
men in all KL grades (<2:p<0.0001, 2:p¼0.0034, 3:p¼0.0002 and
4:p¼0.0106) in unadjusted analyses and in KL grades <4 (<2:p¼0.0020,
2:p¼0.0298, 3:p¼0.0318 and 4:p¼0.1128) in adjusted analyses.
In unadjusted analyses, lower function and greater disability were found in
women compared withmen at KL grade<2/<2 (p<0.0001). There were no
sex differences in the KL grade group with an osteophyte in the index but
not contralateral knee (2/<2), while in those with osteophyte in both
knees (2/2) women had lower function (p¼0.0380) but not more disability
than men. With unilateral (3/<2) and bilateral (3/3) joint space narrowing,
women had lower function (p¼0.0004 and p¼0.0009) and greater
disability (p¼0.0189 and p¼0.0270) compared with men that remained
signiﬁcant in adjusted analyses (Table). No signiﬁcant differences were
found in KL grade group 3/2. Finally, in KL grade group 4/0-4, women had
greater disability (p¼0.0009), that remained signiﬁcant after adjustment,
but not lower function compared with men.Adjusted Mean Function and Disability Scores in Women Compared with Men
(LSmeans±SE)









<2/<2 n¼1463 F 10.70.3 0.1458 78.70.5 0.0595
M 9.90.4 80.20.6
2/<2 n¼300 F 14.40.8 0.0412 79.81.0 0.9129
M 11.80.9 79.61.3
2/2 n¼140 F 17.41.0 0.5034 75.81.2 0.8673
M 15.82.1 75.32.7
3/<2 n¼223 F 19.11.1 0.0104 75.51.3 0.1097
M 14.91.2 78.61.4
3/2 n¼132 F 19.81.3 0.8936 73.71.6 0.4512
M 20.11.8 75.92.2
3/3 n¼183 F 22.41.0 0.0093 73.31.2 0.1335
M 17.51.5 76.41.6
4/0-4 n¼290 F 22.80.8 0.4445 71.80.9 0.0220
M 23.80.9 75.11.0Conclusions: Greater severity of knee pain, poorer function and increased
disability in women appears to be independent of greater severity of
tibiofemoral radiographic OA.355
ESTIMATING PROSTHESIS SURVIVAL FOLLOWING TOTAL HIP
REPLACEMENT IN THE UNITED KINGDOM
D. Culliford 1, A. Judge 2,1, J. Maskell 1, N. Arden 2,1. 1Univ. of Southampton,
Southampton, United Kingdom; 2Univ. of Oxford, Oxford, United Kingdom
Purpose: To produce population-based estimates for the elapsed time
from total hip replacement to revision surgery in the United Kingdom.
These estimates will provide survival estimates for a large cohort with up
to 16 years of follow-up.
Methods: We used data from the U.K. General Practice Research Database
(GPRD) which contains all the computerised records of 6.25m patients,
and is representative of the population of the U.K. We collected data on all
THRs (N¼28,068) performed between 1991 and 2006. Cox proportional
hazards models were used to estimate time to revision surgery following
a primary replacement, after adjusting for age, gender and body mass
index (BMI). Survival at 1, 3, 5, 10 and 15 years was estimated, as well as for
all subjects undergoing replacement at any point during the study period
(1991 to 2006 inclusive). Kaplan-Meier estimates were used to provide
point and interval estimates for the proportion remaining free of revision
surgery.
Results: The Kaplan-Meier (Product-Limit) estimator was used to obtain
the survival estimate for THR subjects remaining free of revision surgery,
which at 1 year was 99.40% (95% CI: 99.49%,99.30%), at 3 years 98.83% (95%
CI: 98.98%,98.66%), at 5 years 98.24% (95% CI: 98.46%,97.99%), at 10 years
95.54% (95% CI: 96.21%,94.76%), at 15 years 89.11% (95% CI: 91.52%,86.07%)
and at the study endpoint 90.16% (95% CI: 91.85%,88.16%). The age-adjusted
Cox model estimates at 5 years showed a greater risk of THR revision for
men than women (HR 1.38 ,95% CI: 1.05,1.82,p¼0.021), but this was not
signiﬁcant after additionally adjusting for BMI (HR 1.20 ,95% CI:
0.70,2.05,p¼0.499). We also found that a BMI in the 30 to 35 range was
a signiﬁcant predictor of time to THR revision at 5 years (HR 2.63 ,95% CI:
1.27,5.46,p¼0.010) relative to the 18.5 to 25 range after adjusting for age
and gender, although not at other time points. The over 35 BMI group only
showed a trend towards signiﬁcance at 5 years (HR 2.65 ,95% CI:
0.87,8.08,p¼0.088), but the effect size was almost identical to the 30 to 35
group estimate.
Conclusions: Using standard methods of survival analysis on a large,
population-based dataset, we have estimated the proportion of THRs
revised at different time points with amaximum follow-up of 16 years. Our
estimates are lower than those reported in registry data, and the expla-
nations for this require further work. In spite of the fact that pre-operative
BMI is only available in a subset of GPRD subjects undergoing THR, we
were still able to show a signiﬁcant association with an elevated risk of
THR revision at 5 years. We are currently taking delivery of ﬁvemore years
of follow-up data for this GPRD cohort, giving over 20 years of follow-up
for some subjects. We fully expect that this extended cohort will soon yield
further results of interest relating to BMI, and this may shed more light on
our BMI ﬁnding at 5 years post-THR.
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